Maven Securities LTD Macrogenics Inc Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $286,860 - $498,820	-14,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.99 - $33.2 $265,860 - $464,800	14,000 New	14,000 $440,000
Q2 2018 Aug 13, 2018	SELL	$19.78 - $24.67 $829,869 - $1.04 Million	-41,955 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.89 - $32.46 $792,529 - $1.36 Million	41,955 New	41,955 $1.06 Million

155

60.6M

218K

259K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $221M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.